SCHEMBL4687618

SCHEMBL4687618

O=C1C(Cc2ccccc2)c2c(O)cccc2N1c1cc(Cl)cc(Cl)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB2 P05107 1/20 0.41
ICAM1 P05362 1/20 0.41
ITGAL P20701 1/20 0.41
SPR P35270 2/20 0.39
EP300 Q09472 1/20 0.39
ACLY P53396 1/20 0.37
MMP2 P08253 2/20 0.37
GAA P10253 2/20 0.37
MEN1 O00255 2/20 0.37
ALDH1A1 P00352 2/20 0.37
KMT2A Q03164 2/20 0.37
MAPT P10636 1/20 0.37
ALOX15 P16050 1/20 0.37
ALOX12 P18054 1/20 0.37
HSD17B10 Q99714 1/20 0.37
ALOX5 P09917 2/20 0.36
CES2 O00748 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4687837 0.91 ITGAL (0.40) ITGB2ICAM1ITGALGAAALDH1A1
SCHEMBL4688597 0.82 ALOX5 (0.48) ITGB2ICAM1ITGALMEN1ALDH1A1
SCHEMBL4687956 0.81 ALOX5 (0.50) ITGB2ICAM1ITGALEP300MMP2
SCHEMBL4693030 0.78 GAA (0.39) ITGB2ICAM1ITGALSPREP300
SCHEMBL4689811 0.73 ALOX5 (0.46) ITGB2ICAM1ITGALGAAMEN1
SCHEMBL4692248 0.72 ALOX5 (0.47) ITGB2ICAM1ITGALALOX5CES2
SCHEMBL4690051 0.71 ALOX5 (0.46) ITGB2ICAM1ITGALMEN1ALDH1A1
SCHEMBL4692140 0.68 ITGAL (0.38) ITGB2ICAM1ITGALALOX5CES2
SCHEMBL4690039 0.68 ITGAL (0.70) ITGB2ICAM1ITGALALDH1A1CYP1A2
SCHEMBL4689907 0.65 ITGAL (0.36) ITGB2ICAM1ITGALMAPTALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1399155-B1 SMALL MOLECULES USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASE BOEHRINGER INGELHEIM PHARMA (US) 2008-05-28 EP claimed
US-6414153-B1 TREATMENT OF INFLAMMATORY OR IMMUNE CELL-MEDIATED DISEASE OR CONDITION BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2002-07-02 US claimed
EP-1399155-B1 SMALL MOLECULES USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASE BOEHRINGER INGELHEIM PHARMA (US) 2008-05-28 EP disclosed
US-6414153-B1 TREATMENT OF INFLAMMATORY OR IMMUNE CELL-MEDIATED DISEASE OR CONDITION BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2002-07-02 US disclosed